The Foundation Fighting Blindness is committed to finding treatments and cures for blinding retinal diseases that affect more than 10 million people in the Unit... More
5 of 100
Eye on the Cure Podcast | Episode 46: Aaron Osborne, MD
Aaron Osborne, MD, chief medical officer and chief development officer at Nanoscope Therapeutics, talks about vision restoration in clinical trials of the company's optogenetic therapy for people with advanced vision loss from retinitis pigmentosa and Stargardt disease.
Atsena Receives FDA Authorization to Launch a Gene Therapy Clinical Trial for XLRS
Known as The Lighthouse Study, the Phase 1/2 trial is expected to begin in mid-2023
Eric Pierce Receives Proctor Medal for Outstanding Achievements in Retinal Research
During his Proctor Award Lecture, Dr. Pierce reviewed encouraging clinical trial results for Editas’ CRISPR/Cas9 treatment for people with LCA10
News | Budd Tucker Honored with Award for Advancements in Retinal Therapy Development
News | Budd Tucker Honored with Award for Advancements in Retinal Therapy Development by Foundation Fighting Blindness
Eye on the Cure Podcast | Episode 45: Henry Klassen, MD, PhD
April 28, 2023. Henry Klassen, MD, PhD, co-founder of jCyte and clinical researcher at UC Irvine, talks to host Ben Shaberman about jCyte's clinical trial results and future plans for developing its cell-based therapy for preserving vision caused by retinitis pigmentosa, Usher syndrome, and related retinal conditions.
The Foundation Fighting Blindness is committed to finding treatments and cures for blinding retinal diseases that affect more than 10 million people in the United States. To learn more, go to FightingBlindness.org.